Write a reviewFor vendors
♡
Home / Investors / Kelly Moynihan

Kelly Moynihan

Venture Fund · Seattle

About Kelly Moynihan

Venture capital investor (Senior Associate) based in Seattle, Washington. Focus areas include Health Care, Drug Discovery, Autoimmune Diseases. Past investments include Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics.

Investment focus

Sectors
Health CareDrug DiscoveryAutoimmune DiseasesWellnessWomen FoundedRare DiseasesHealthcare InnovationLife ScienceEngineeringMedical TechnologiesStartupsBusiness DevelopmentBiotechnologyMedical DevicesDrug DevelopmentEntrepreneurshipGenomicsWearable TechnologyPrecision MedicineInnovation

Portfolio

No portfolio companies recorded yet; Kelly Moynihan reports 57 investments overall.

Similar investors

'- Kevin Petry -

Accelerator · Winter Park
AdvertisingHealth CareE-commerceAccounting+16
60Investments
—Exits

Aakash Patel

Venture Fund · New York City
Health CareCommercialTalent ManagementWearables+16
60Investments
—Exits

Aakash Tulsani

Venture Fund · Singapore
Series BHealth CareHospitalsE-commerceSports+16
60Investments
—Exits

Aaref Hilaly

Angel Investor · San Francisco
SeedSeries BEarly Stage VentureSeries AHealth CareData IntegrationTalent ManagementE-commerce+16
60Investments
—Exits

Aaron Bast

Venture Fund · Kitchener
SeedEarly Stage VentureAdvertisingHealth CareAccountingPayments+16
60Investments
—Exits

Aaron Block

Angel Investor · New York City
Early Stage VentureAdvertisingHealth CareWomen FoundedEnterprise Software+16
60Investments
—Exits